Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI.

Brandt AS, Kamper L, Kukuk S, Piroth W, Haage P, Roth S.

J Clin Med Res. 2013 Feb;5(1):49-56. doi: 10.4021/jocmr1254e. Epub 2013 Jan 11.

2.

Ormond's disease or secondary retroperitoneal fibrosis? An overview of retroperitoneal fibrosis.

Heckmann M, Uder M, Kuefner MA, Heinrich MC.

Rofo. 2009 Apr;181(4):317-23. doi: 10.1055/s-2008-1027881. Epub 2009 Mar 16. Review.

PMID:
19291600
3.

Prognostic factors in retroperitoneal fibrosis.

Sinescu I, Surcel C, Mirvald C, Chibelean C, Gîngu C, Avram D, Hîrza M, Manu M, Lazar R, Savu C, Udrea A.

J Med Life. 2010 Jan-Mar;3(1):19-25. Retraction in: J Med Life. 2012 Jun 12;5(2):246-7.

4.

Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis.

Brandt AS, Kamper L, Kukuk S, Haage P, Roth S.

Urol Int. 2014;93(3):320-5. doi: 10.1159/000357814. Epub 2014 Jul 26.

5.

Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration.

Kardar AH, Kattan S, Lindstedt E, Hanash K.

J Urol. 2002 Aug;168(2):550-5.

PMID:
12131307
6.

Treatment of retroperitoneal fibrosis with tamoxifen: case report and review of literature.

Puce R, Porcaro AB, Curti P, Girelli D, Pantalena M, Malossini G, Tallarigo C.

Arch Esp Urol. 2000 Mar;53(2):184-90. Review.

PMID:
10802927
7.

Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography.

Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, Salvarani C, Buzio C.

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):231-4.

PMID:
15895895
8.

[Treatment outcomes in primary and secondary retroperitoneal fibrosis].

Heidenreich A, Derakhshani P, Neubauer S, Krug B.

Urologe A. 2000 Mar;39(2):141-8. German.

PMID:
10768224
9.

Role of gadolinium-enhanced magnetic resonance imaging in retroperitoneal fibrosis.

Burn PR, Singh S, Barbar S, Boustead G, King CM.

Can Assoc Radiol J. 2002 Jun;53(3):168-70.

PMID:
12101539
10.

Management of idiopathic retroperitoneal fibrosis from the urologist's perspective.

Cristian S, Cristian M, Cristian P, Constantin G, Savu C, Huri E, Sinescu I.

Ther Adv Urol. 2015 Apr;7(2):85-99. doi: 10.1177/1756287214565637. Review. Erratum in: Ther Adv Urol. 2016 Apr;8(2):161-2.

11.

MR evaluation of retroperitoneal fibrosis.

Kamper L, Brandt AS, Scharwächter C, Kukuk S, Roth S, Haage P, Piroth W.

Rofo. 2011 Aug;183(8):721-6. doi: 10.1055/s-0031-1273450. Epub 2011 Jul 11.

PMID:
21748695
12.

Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches.

Moroni G, Gallelli B, Banfi G, Sandri S, Messa P, Ponticelli C.

Nephrol Dial Transplant. 2006 Sep;21(9):2485-90. Epub 2006 May 15.

13.

Retroperitoneal fibrosis with pancreatic involvement - radiological appearance.

Zielonko J, Obołończyk L.

Pol J Radiol. 2011 Oct;76(4):69-72.

14.

Positron emission tomography as a tool for the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience.

Piccoli GB, Consiglio V, Arena V, Pelosi E, Anastasios D, Ragni F, Fiori C, Cortese G, Deagostini MC, Porpiglia F, Scarpa RM.

Nephrol Dial Transplant. 2010 Aug;25(8):2603-10. doi: 10.1093/ndt/gfq051. Epub 2010 Feb 15.

15.

[Ormond's fibrosis, bone osteolysis and stomach intramural metastases in the course f low-differentiated prostatic cancer].

Stajszczyk M, Mykała-Cieśla J, Machalski M, Pajak J.

Pol Arch Med Wewn. 2001 Jul;106(1):593-600. Polish.

PMID:
11928571
16.

[Idiopathic retroperitoneal fibrosis (Ormond's disease)].

Nelius T, Reiher F, Lindenmeir T, Kalinski T, Rau O, Filleur S, Allhoff EP.

Aktuelle Urol. 2006 Jul;37(4):284-8. German.

PMID:
16878283
17.

(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.

Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF.

Eur J Intern Med. 2010 Jun;21(3):216-21. doi: 10.1016/j.ejim.2010.02.008. Epub 2010 Mar 28.

PMID:
20493425
18.

Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients.

Mirault T, Lambert M, Puech P, Argatu D, Renaud A, Duhamel A, Glovacki F, Villers A, Hachulla E, Biserte J, Hatron PY, Lemaitre L.

Medicine (Baltimore). 2012 Sep;91(5):242-50. doi: 10.1097/MD.0b013e31826b1c1d.

19.

Idiopathic retroperitoneal fibrosis in a patient suspected of impending rupture of the abdominal aortic aneurysm.

Takahashi J, Wakamatsu Y, Okude J, Gohda T, Sanefuji Y, Sasaki S, Matsui Y.

Ann Thorac Cardiovasc Surg. 2008 Feb;14(1):55-9.

PMID:
18292744
20.

Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.

Pelkmans LG, Aarnoudse AJ, Hendriksz TR, van Bommel EF.

Nephrol Dial Transplant. 2012 Jul;27(7):2819-25. doi: 10.1093/ndt/gfr779. Epub 2012 Jan 23.

Items per page

Supplemental Content

Write to the Help Desk